When I opened my own practice in 2020, I knew I wanted to reimagine the traditional eyecare practice and give patients an unparalleled experience that balances a tech-forward philosophy with personalized care and a human touch. That’s why I was the first practitioner to purchase OptiLight.

With a major dry eye center in the high desert of Arizona, I need to be on top of new advances in dry eye therapy. It was exciting to see Lumenis, the company that first introduced intense pulsed light (IPL) technology, receive the first and only FDA approval of IPL for management of dry eye disease for Lumenis IPL with Optimal Pulse Technology (OPT™).

Ocular surface disease is persistent and progressive, and it affects vision and quality of life for so many patients. In my practice, the goal is to get ahead of the problem early, when treatment is most effective.

Students often ask me, “Will all of this education, training and money be worth it in the long run? Can we have long, viable careers in optometry?” The answer is an emphatic yes, and the key to making it happen is diversification.

When I saw Optima IPL at a conference in 2018, it was love at first sight. By treating peri-ocular rosacea, and thus the underlying inflammation that causes meibomian gland dysfunction (MGD) and dry eye, Optima IPL would fulfill a key unmet need and take a...

Flying home from a conference on March 7th, absorbing the latest news about COVID-19, I knew I needed to implement a shutdown strategy upon my return. When we closed on March 21st, we were prepared to continue remote services where possible and stay connected with...

In optometry, where diagnosis often depends on getting a magnified view through the slit lamp with stains and dyes and using point-of-care tests, telemedicine has limited use in terms of billable visits. But the mechanisms of telemedicine have tremendous value…